http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112618542-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4174 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4174 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 |
filingDate | 2021-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-112618542-B |
titleOfInvention | Application of HSP70 inhibitors with broad-spectrum anti-flaviral activity |
abstract | The present invention relates to the application of HSP70 inhibitor broad-spectrum anti-flavivirus activity, and specifically provides the use of the compound represented by formula I in the preparation of medicine for treating or preventing viral infectious diseases of Flaviviridae. The compound has broad-spectrum anti-flaviral activity and exhibits good lesion protection against 4 flaviviruses including Zika virus, dengue virus, Japanese encephalitis virus and yellow fever virus in 3 different cell lines. Good druggability. |
priorityDate | 2020-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 241.